Código QR (código de barras bidimensional)

Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial

Background Enavogliflozin is a novel sodium-glucose cotransporter-2 inhibitor currently under clinical development. This study evaluated the efficacy and safety of enavogliflozin as an add-on to metformin in Korean patients with type 2 diabetes mellitus (T2DM) against dapagliflozin. Methods In this...

Fuld beskrivelse

Na minha lista:
Principais autores: Kyung Ah Han, Yong Hyun Kim, Doo Man Kim, Byung Wan Lee, Suk Chon, Tae Seo Sohn, In Kyung Jeong, Eun-Gyoung Hong, Jang Won Son, Jae Jin Nah, Hwa Rang Song, Seong In Cho, Seung-Ah Cho, Kun Ho Yoon
Format: Artigo
Sprog:Inglês
Udgivet: Korean Diabetes Association 2023-11-01
Serier:Diabetes & Metabolism Journal
Fag:
dapagliflozin
diabetes mellitus, type 2
hypoglycemic agents
metformin
randomized controlled trial
sodium-glucose transporter 2 inhibitors
Online adgang:http://www.e-dmj.org/upload/pdf/dmj-2022-0315.pdf
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker